SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alliance Pharmaceutical
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: All Mtn Ski who wrote (500)9/12/2000 1:17:18 PM
From: Cacaito  Read Replies (1) of 548
 
Allp will probably have a $1 billion plus product Oxygent, multiply those sales x 10 and $10 billion is a decent market value, this is about $170 per share just base on Oxygent.

Imagent should add some $30 per share.

The Inhale Therapeutics shares and pulmospheres should add some $20

Liquivent IF it works will add another $40.

Total of $260 in 5 years, cut that with a 100% dilution and still one get $180 per share, easily 11 times current value.

Dilution could not be a lot cause of Bax and INHL deals cash infusion.

Of course, it seems that UBS, the swiss who bought Paine Webber? will do a huge 2ry offering soon.

All speculation, all disclaimers do not apply.
For entertainment purposes only.

I am in (again) at $17.

Greetings T Dude if you still are in, Greetings anyway if you got out at a profit.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News